The classification of breast cancer can be based on molecular receptor expression, and the receptors include estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), with the proliferation index marker Ki67. Here, ERBB2 is linked to breast carcinoma.